If you have cancer or are at risk at getting cancer take ONLY the anti cancer superantioxidants – switch superantioxidants – See Start Page!
Don’t Overdose!
Do not take if you are breastfeeding or pregnant!
A Varied Diet Is Not Enough For Longevity! SuperAntioxidants FTW!
The Whole Website Is Not A Commercial! It’s 7 Years Of Research – Trial & Error!
Don’t Overdose!
Consult the doctor first. Medicines are usually better at alleviating, but super antioxidants, in turn, give longer life, which medicines can also give, of course. They complement each other, and both are good in the prescribed dose.
Author: Christoffer Mikael Lyckholm Skeneby
See Start Tab/Page For Cancer Safe SuperAntioxidants!
Continue Below If You Do Not Have Or Are Not At Risk Of Getting Cancer!
www.ChristofferLyckholm.Com
“MitoQ is a breakthrough cell health molecule that enhances your energy and vitality at a deep foundational level, so you can get more out of life.” Source: MitoQ.com
https://www.mitoq.com/journal/29-things-you-probably-didnt-know-about-mitoq
1: Arterial Function
2: Cancer
3: HIV and Organ Health
Slows down and alleviates many chronic diseases.
1: Arterial Function
In an Colorado Boulder clinical trial they found out that MItoQ significantly supports arterial function. Six weeks was enough for MitoQ to work. In this weeks it helped the arteries to dilate by 42%. Moreover they found out that MitoQ significantly reduces oxidative stress.
Flexible arteries is important for optimal blood flow. “Novel antioxidant makes old blood vessels seem young again” https://www.colorado.edu/today/2018/04/19/novel-antioxidant-makes-old-blood-vessels-seem-young-again
2: Cancer
“MitoQ Inhibits Human Breast Cancer Cell Migration, Invasion and Clonogenicity”
“Here, we tested MitoQ, a mitochondria-targeted ROS inactivator that already successfully passed Phase I safety clinical trials, as a potential inhibitor of the early steps of the metastatic cascade. Using human breast cancer cells as models in anticipation of preclinical and clinical assays, we report that MitoQ inhibits cancer cell migration, invasion, clonogenicity, sphere formation and spheroid stability.”
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946220/
3: HIV and Organ Health
“The mitochondrial antioxidant mitoquinone mesylate (MitoQ) attenuates mitochondrial dysfunction in preclinical mouse models of various diseases but has not been used in HIV”
https://pubmed.ncbi.nlm.nih.gov/36958371/
“treated with antiretroviral therapy and MitoQ for 90 days had higher ratios of human and murine mitochondrial to nuclear DNA in end organs compared with HIV-1-infected mice on antiretroviral therapy. We offer translational evidence of MitoQ as treatment for mitochondrial dysfunction in HIV.”
https://pubmed.ncbi.nlm.nih.gov/36958371/
SuperAntioxidants 